Geneva Advisors’s Cardinal Health CAH Stock Holding History

Geneva Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$533K	Sell	6,838 -51	-0.7%	-$3.85K	0.01%	501
2017 Q1	$562K	Sell	6,889 -26	-0.4%	-$2.05K	0.01%	479
2016 Q4	$498K	Buy	6,915 +75	+1%	+$5.42K	0.01%	478
2016 Q3	$531K	Buy	6,840 +25	+0.4%	+$2.02K	0.01%	453
2016 Q2	$532K	Sell	6,815 -267,335	-98%	-$21.3M	0.01%	432
2016 Q1	$22.5M	Sell	274,150 -282,570	-51%	-$23M	0.45%	65
2015 Q4	$49.7M	Buy	556,720 +172,600	+45%	+$14.7M	0.96%	36
2015 Q3	$29.5M	Sell	384,120 -8,811	-2%	-$736K	0.6%	54
2015 Q2	$32.9M	Buy	392,931 +4,414	+1%	+$390K	0.59%	58
2015 Q1	$35.1M	Buy	388,517 +2,715	+0.7%	+$234K	0.63%	55
2014 Q4	$31.1M	Buy	385,802 +382,816	+12,820%	+$30.2M	0.58%	62
2014 Q3	$224K	Hold	2,986	–	–	﹤0.01%	574
2014 Q2	$205K	Sell	2,986 -300	-9%	-$20.4K	﹤0.01%	591
2014 Q1	$230K	Buy	+3,286	New	+$229K	﹤0.01%	536

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return

Geneva Advisors's CAH Position: Q2 2017 in Review

Geneva Advisors reduced its Cardinal Health (CAH) stake by 0.74% in Q2 2017, selling an estimated $3.85K and leaving 6,838 shares worth $533K. The position accounts for 0.01% of the portfolio, ranked #501.

Geneva Advisors first reported a position in CAH in Q1 2014 and has held it in 14 quarters since. The position peaked at $49.7M in Q4 2015. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.

Geneva Advisors held 6,838 shares of Cardinal Health worth $533K as of Q2 2017.
Geneva Advisors sold 51 Cardinal Health shares in Q2 2017, an estimated $3.85K.
Cardinal Health made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #501 holding.
Geneva Advisors first reported a position in Cardinal Health in Q1 2014 and has held it in 14 quarters since.
Geneva Advisors's Cardinal Health position peaked at $49.7M in Q4 2015.
747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.